Aurobindo Pharma’s stepdown subsidiary, Eugia Steriles Private Ltd, has received its first product approval from the US FDA for Lidocaine Hydrochloride injection. The approval came after an inspection of their new injectables manufacturing facility in Andhra Pradesh. This achievement is pivotal for Aurobindo Pharma’s expansion plans.
Related Posts
FD rule changes: Multiple nominees to be allowed for fixed deposits soon? Check proposed modifications
FD nomination changes: Parliament is considering legislation to allow multiple nominees for fixed deposits, aiming to simplify inheritance for families. The proposed changes would permit […]
Didn’t pay over Rs 3,500cr in TDS & PF, admits SpiceJet
SpiceJet has revealed it failed to pay Rs 2,200 crore in TDS deducted from employees’ salaries and Rs 1,353 crore in PF from April 2020 […]